Biotech champion, QB3 leader Reg Kelly to retire


David Schaffer, a research giant at UC Berkeley, will take over as executive director of QB3, which support scientists at Berkeley, UCSF and UC Santa Cruz and helps research spin out from academic labs to patient bedsides.

Previous Durham biotech follows billion-dollar Novartis deal with $50M offering
Next Arlington med-tech firm gets more backing from Halcyon networks ahead of a product launch